FirasEl ChaerMD

Assistant Professor of Medicine and Infusion Center Medical Director

Overview of Dr. El Chaer

Dr. Firas El Chaer is an oncologist and hematologist in Charlottesville, VA and is affiliated with the University of Virginia Medical Center. He received his medical degree from University of Balamand Faculty of Medicine and has been in practice 5 years. He also speaks multiple languages, including English, Arabic and French. He is experienced in myeloproliferative disorders, aplastic anemia, acute leukemia, myelodysplastic syndromes, bone marrow failure syndromes, chronic myeloid leukemia and general internal medicine.

Office
University of Virginia Health System
PO Box 800716
Charlottesville, VA 22908
Book by Phone+1(229) 321-5019

Fax+1 434-244-7526

Education & Training

University of MarylandFellowship, Hematology and Medical Oncology, 2016 - 2019
Baylor College of MedicineFellowship, Infectious Disease, 2014 - 2016
University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2014 - 2016
Hackensack University Medical Center/Englewood Hospital and Medical CenterResidency, Internal Medicine, 2011 - 2014
University of Balamand Faculty of MedicineClass of 2011

Certifications & Licensure

VA State Medical License 2018 - 2026
NJ State Medical License 2012 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Internal Medicine Residency Inpatient Attending of the Year University of Virginia, 2022
Department of Medicine Excellence in Research Award University of Virginia, 2021
Fellow Teaching Award University of Maryland Medical Center, 2018
PGY3 Leadership Award Icahn School of Medicine at Mount Sinai, Englewood Program, 2014
Excellence in Critical Care Award Icahn School of Medicine at Mount Sinai, Englewood Program, 2014
PGY2 Leadership Award Icahn School of Medicine at Mount Sinai, Englewood Program, 2013
Arnold P. Gold Foundation Humanism and Excellence in Teaching Award Icahn School of Medicine at Mount Sinai, 2012
Arnold P. Gold Foundation Outstanding Resident Role Model Award Icahn School of Medicine at Mount Sinai, 2012
PGY1 Leadership Award Icahn School of Medicine at Mount Sinai, Englewood Program, 2012
Join now to see all

Clinical Trials

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001) Start of enrollment: 2022 Nov 29
Recruiting
Early Phase 1
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS Start of enrollment: 2020 Aug 19
Recruiting
Phase 2

Publications & Presentations

PubMed

20 citations
How I treat AML incorporating the updated classifications and guidelines.
Firas El Chaer, Christopher S Hourigan, Amer M Zeidan
Blood. 2023-06-08
1 citations
Post-Hematopoietic Cell Transplantation Relapsed Acute Lymphoblastic Leukemia: Current Challenges and Future Directions.
Indumathy Varadarajan, Eric Pierce, Lisa Scheuing, Amy Morris, Firas El Chaer
Oncotargets and Therapy. 2023-01-01
2 citations
Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?
Firas El Chaer, Karen K Ballen
Bone Marrow Transplantation. 2022-10-01

Abstracts/Posters

Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...
Firas El Chaer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

How Targeted Therapies are Affecting the Cancer Care Team: A Conversation With Dr. Firas El ChaerFebruary 25th, 2020
The role of post-transplant maintenance therapy in AMLMay 25th, 2022
Advances & unmet needs in APLMay 25th, 2022